Role of Silymarin in Neuroprotection and Symptom Management in Parkinson's Disease

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
Parkinson\'s disease (PD) is a leading neurodegenerative movement disorder, marked by a gradual loss of dopamine-producing neurons in the substantia nigra pars compacta (SNpc) and the accumulation of α-synuclein protein aggregates. Silymarin, a polyphenolic flavonoid renowned for its potent antioxidant properties, will be studied for its neuroprotective effects in PD.
Epistemonikos ID: 48640614f23bcce3e9911d26c0d27618c2fa458a
First added on: Jul 01, 2025